EDITORIAL LETTER


Welcome to our Spotlight supplement!


Dear colleague,


It is my pleasure to welcome you to this special Oncology Central interactive supplement, which we have created to bring you the highlights of our recent Spotlight focus on circulating tumor cells (CTCs) for liquid biopsy of cancer.


4


The potential of liquid biopsy in oncology has generated significant interest over the last decade and this interest continues to build, as it offers the potential to simply and accurately isolate and analyze key biomarkers for personalizing cancer therapy. Within liquid biopsy, the detection and molecular characterization of CTCs is an active area of research.


During the course of this 3-month focus, we looked into the potential of CTCs for liquid biopsy of cancer, highlighting news and key Future Science Group journal content discussing the topic, and posing key questions about the current and future applications of CTCs.


We also asked you to share your opinions on CTCs, their potential, and the challenges associated with CTC research and utility in our Spotlight survey. Almost half of our respondents believe that CTCs could be adopted as a key part of the clinical decision-making process within the next 3 years,


Almost half of our respondents believe that CTCs could be adopted as a key part of the clinical decision-making process within the next 3 years, and 51% of respondents suggested that


CTCs are an area of priority within their institution.


and 51% of respondents suggested that CTCs are an area of priority within their institution. Continue exploring our special supplement to gain a visual snapshot of what our respondents believe is the current status of this field and the perceived road ahead in our stunning survey infographic.


Within this supplement, you will also find a range of journal content focused on CTCs, from basic biology through to potential clinical applications. I hope you enjoy all that this special supplement holds and welcome feedback, comments or suggestions. Are there any topic areas you would like to see covered in further Spotlights on Oncology Central? Let me know!


Emily Brown Editor, Oncology Central


Oncology Central, Unitec House, 2 Albert Place, London N3 1QB www.oncology-central.com


EDITOR


Emily Brown e.brown@oncology-central.com


BUSINESS DEVELOPMENT MANAGER Andy Kemp a.kemp@future-science-group.com +44 208 371 6090


COPYRIGHT Future Science Group Ltd. All rights reserved. Reproduction in whole or in part is forbidden without the express permission of the publishers. Registered in England & Wales, No: 4059017.


Please send your press releases to: e.brown@oncology-central.com Images © Shutterstock.com, unless otherwise stated Original concept design spike@spikedesigns.co.uk


www.oncology-central.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14